Tilray Inc (NASDAQ:TLRY - Get Free Report) was up 2% during trading on Tuesday . The company traded as high as $1.84 and last traded at $1.82. Approximately 13,246,352 shares changed hands during trading, a decline of 55% from the average daily volume of 29,125,699 shares. The stock had previously closed at $1.78.
Wall Street Analyst Weigh In
A number of research analysts have commented on TLRY shares. Alliance Global Partners increased their price target on shares of Tilray from $2.25 to $2.75 and gave the company a "neutral" rating in a research report on Friday, April 5th. Canaccord Genuity Group reduced their price target on shares of Tilray from $4.25 to $4.00 and set a "buy" rating on the stock in a research report on Wednesday, April 10th. Finally, CIBC reduced their price target on shares of Tilray from $2.25 to $2.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 10th.
Read Our Latest Stock Report on TLRY
Tilray Stock Performance
The business has a 50 day moving average price of $1.97 and a two-hundred day moving average price of $1.97. The stock has a market cap of $1.36 billion, a PE ratio of -4.16 and a beta of 2.36. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.92 and a quick ratio of 1.18.
Institutional Trading of Tilray
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Clear Street Markets LLC bought a new stake in shares of Tilray during the 3rd quarter valued at $25,000. Macquarie Group Ltd. raised its position in shares of Tilray by 188.8% in the 2nd quarter. Macquarie Group Ltd. now owns 8,540 shares of the company's stock worth $27,000 after purchasing an additional 5,583 shares during the last quarter. Oppenheimer & Co. Inc. purchased a new position in shares of Tilray in the 4th quarter worth about $27,000. Lake Street Financial LLC purchased a new position in shares of Tilray in the 3rd quarter worth about $28,000. Finally, Gainplan LLC purchased a new position in shares of Tilray in the 4th quarter worth about $28,000. Hedge funds and other institutional investors own 9.35% of the company's stock.
About Tilray
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
See Also
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
